chr2-72132271-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_019885.4(CYP26B1):c.1495G>A(p.Glu499Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,604,930 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_019885.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP26B1 | NM_019885.4 | c.1495G>A | p.Glu499Lys | missense_variant | 6/6 | ENST00000001146.7 | NP_063938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP26B1 | ENST00000001146.7 | c.1495G>A | p.Glu499Lys | missense_variant | 6/6 | 1 | NM_019885.4 | ENSP00000001146 | P1 | |
CYP26B1 | ENST00000546307.5 | c.1270G>A | p.Glu424Lys | missense_variant | 5/5 | 1 | ENSP00000443304 | |||
CYP26B1 | ENST00000412253.1 | c.922G>A | p.Glu308Lys | missense_variant | 5/5 | 1 | ENSP00000401465 |
Frequencies
GnomAD3 genomes AF: 0.000815 AC: 124AN: 152174Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000183 AC: 42AN: 230034Hom.: 0 AF XY: 0.000153 AC XY: 19AN XY: 124292
GnomAD4 exome AF: 0.0000675 AC: 98AN: 1452638Hom.: 1 Cov.: 32 AF XY: 0.0000624 AC XY: 45AN XY: 721638
GnomAD4 genome AF: 0.000821 AC: 125AN: 152292Hom.: 0 Cov.: 33 AF XY: 0.000873 AC XY: 65AN XY: 74454
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
CYP26B1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 06, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 02, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at